AA147 Alleviates Symptoms in a Mouse Model of Multiple Sclerosis by Reducing Oligodendrocyte Loss
Glia · 2025-06 · 73 (6) · 1241-1257
DOI: 10.1002/glia.70001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, online erschienen am 10.02.2025. Verfasst von Metin Aksu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Loyola University Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Oligodendroglia, Encephalomyelitis, Autoimmune, Experimental, Multiple Sclerosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, National Multiple Sclerosis Society.
Abstract (Originalsprache)
Inflammation‐induced oligodendrocyte death and CNS demyelination are key features of multiple sclerosis (MS). Inflammation‐triggered endoplasmic reticulum (ER) stress and oxidative stress promote tissue damage in MS and in its preclinical animal model, experimental autoimmune encephalitis (EAE). Compound AA147 is a potent activator of the ATF6 signaling arm of the unfolded protein response (UPR) that can also induce antioxidant signaling through activation of the NRF2 pathway in neuronal cells. Previous work showed that AA147 protects multiple tissues against ischemia/reperfusion damage through ATF6 and/or NRF2 activation; however, its therapeutic potential in neuroinflammatory disorders remains unexplored. Here, we demonstrate that AA147 ameliorated the clinical symptoms of EAE and reduced ER stress, oligodendrocyte loss, and demyelination. Additionally, AA147 suppressed T cells in the CNS without altering the peripheral immune response. Importantly, AA147 significantly increased the expressions of Grp78 , an ATF6 target gene, in oligodendrocytes, while enhancing levels of Grp78 as well as Ho‐1 , an NRF2 target gene, in microglia. In cultured oligodendrocytes, AA147 promoted nuclear translocation of ATF6, but not NRF2. Intriguingly, AA147 altered the microglia activation profile, possibly by triggering the NRF2 pathway. AA147 was not therapeutically beneficial during the acute EAE stage in mice lacking ATF6 in oligodendrocytes, indicating that protection primarily involves ATF6 activation in these cells. Overall, our results suggest AA147 as a potential therapeutic opportunity for MS by promoting oligodendrocyte survival and regulating microglia status through distinct mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Loyola University Chicago, Chicago, Illinois, USA.
- Department of Microbiology-Immunology, Northwestern University, Chicago, Illinois, USA.
- Department of Chemistry, The Scripps Research Institute, La Jolla, California, USA.
- Department of Molecular and Cellular Biology, The Scripps Research Institute, La Jolla, California, USA.
- Department of Neurology, Northwestern University, Chicago, Illinois, USA.
ORCID-Profile: R Luke Wiseman, Stephen D Miller, Brian Popko, Yanan Chen
Förderung
- NIA NIH HHS
- Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
- National Multiple Sclerosis Society
- NIH HHS
- NIH NINDS
- NINDS NIH HHS
- National Institutes of Health
Zitieren
APA
Aksu, M., Kaschke, K., Podojil, J. R., Chiang, M., Steckler, I., Bruce, K., Cogswell, A. C., Schulz, G., Kelly, J. W., Wiseman, R. L., Miller, S. D., Popko, B., & Chen, Y. (2025). AA147 Alleviates Symptoms in a Mouse Model of Multiple Sclerosis by Reducing Oligodendrocyte Loss. Glia, 73(6), 1241-1257. https://doi.org/10.1002/glia.70001
Vancouver
Aksu M, Kaschke K, Podojil JR, Chiang M, Steckler I, Bruce K, et al. AA147 Alleviates Symptoms in a Mouse Model of Multiple Sclerosis by Reducing Oligodendrocyte Loss. Glia. 2025;73(6):1241-1257. doi:10.1002/glia.70001
BibTeX
@article{Aksu2025,
author = {Aksu, Metin and Kaschke, Kevin and Podojil, Joseph R and Chiang, MingYi and Steckler, Ian and Bruce, Kody and Cogswell, Andrew C and Schulz, Gwen and Kelly, Jeffery W and Wiseman, R Luke and Miller, Stephen D and Popko, Brian and Chen, Yanan},
title = {AA147 Alleviates Symptoms in a Mouse Model of Multiple Sclerosis by Reducing Oligodendrocyte Loss},
journal = {Glia},
year = {2025},
volume = {73},
number = {6},
pages = {1241--1257},
doi = {10.1002/glia.70001}
}
EUVIMED